My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance.

    Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB, Gorden P, O'Rahilly S.

    Diabetes Care. 2008 May;31(5):977-9. Epub 2008 Feb 25.PMID: 18299442 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevated plasma adiponectin in humans with genetically defective insulin receptors.

    Semple RK, Soos MA, Luan J, Mitchell CS, Wilson JC, Gurnell M, Cochran EK, Gorden P, Chatterjee VK, Wareham NJ, O'Rahilly S.

    J Clin Endocrinol Metab. 2006 Aug;91(8):3219-23. Epub 2006 May 16.PMID: 16705075 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies.

    Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, Cochran EK, Dunger DB, Wareham NJ, Scherer PE, Gorden P, O'Rahilly S.

    Diabetes. 2007 Jun;56(6):1712-7. Epub 2007 Feb 26.PMID: 17325257 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice.

    Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D.

    Diabetes. 2007 Aug;56(8):1969-76. Epub 2007 May 2.PMID: 17475934 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Combination of C-reactive protein and high molecular weight (HMW)-adiponectin reflects further metabolic abnormalities compared with each of them alone in Japanese type 2 diabetic subjects.

    Saisho Y, Hirose H, Yamamoto Y, Nakatani H, Itoh H.

    Endocr J. 2008 May;55(2):331-8. Epub 2008 Mar 25.PMID: 18362454 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.

    Grigorescu M, Radu C, Crişan D, Grigorescu MD, Serban A, Neculoiu D, Rusu M, Acalovschi M.

    J Gastrointestin Liver Dis. 2008 Jun;17(2):147-54.PMID: 18568135 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.

    Lu JY, Huang KC, Chang LC, Huang YS, Chi YC, Su TC, Chen CL, Yang WS.

    J Biomed Sci. 2008 Sep;15(5):565-76. Epub 2008 Jun 6. Review.PMID: 18535923 [PubMed - indexed for MEDLINE]Related articles

    8.

    Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study.

    Saltevo J, Laakso M, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M.

    Diabetes Metab Res Rev. 2008 Jul-Aug;24(5):378-83.PMID: 18386294 [PubMed - indexed for MEDLINE]Related articles

    9.

    Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance.

    Arner P, Stenson BM, Dungner E, Näslund E, Hoffstedt J, Ryden M, Dahlman I.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2249-54. Epub 2008 Apr 1.PMID: 18381574 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients.

    Fallo F, Dalla Pozza A, Sonino N, Federspil G, Ermani M, Baroselli S, Catena C, Soardo G, Carretta R, Belgrado D, Fabris B, Sechi LA.

    J Hypertens. 2008 Nov;26(11):2191-7.PMID: 18854760 [PubMed - indexed for MEDLINE]Related articles

    11.

    Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk.

    Belobrajdic DP, Priebe IK, Forbes B, Flyvbjerg A, Chen JW, Cosgrove LJ, Frystyk J, Saunders IW.

    Growth Horm IGF Res. 2008 Jun;18(3):198-204. Epub 2007 Oct 24.PMID: 17928251 [PubMed - indexed for MEDLINE]Related articles

    12.

    Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.

    Dalamaga M, Karmaniolas K, Nikolaidou A, Chamberland J, Hsi A, Dionyssiou-Asteriou A, Mantzoros CS.

    Eur J Cancer. 2008 Aug;44(12):1744-53.PMID: 18515085 [PubMed - indexed for MEDLINE]Related articles

    13.

    Distribution of adiponectin, leptin, and metabolic correlates of insulin resistance: a longitudinal study in British children; 1: Prepuberty (EarlyBird 15).

    Murphy MJ, Hosking J, Metcalf BS, Voss LD, Jeffery AN, Sattar N, Williams R, Jeffery J, Wilkin TJ.

    Clin Chem. 2008 Aug;54(8):1298-306. Epub 2008 Jun 6.PMID: 18539644 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese.

    Qi Q, Wang J, Li H, Yu Z, Ye X, Hu FB, Franco OH, Pan A, Liu Y, Lin X.

    Eur J Endocrinol. 2008 Nov;159(5):585-93. Epub 2008 Aug 27.PMID: 18753313 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association of ADIPOR2 with liver function tests in type 2 diabetic subjects.

    López-Bermejo A, Botas-Cervero P, Ortega-Delgado F, Delgado E, García-Gil MM, Funahashi T, Ricart W, Fernández-Real JM.

    Obesity (Silver Spring). 2008 Oct;16(10):2308-13. Epub 2008 Jul 24.PMID: 18719649 [PubMed - indexed for MEDLINE]Related articles

    16.

    Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo: response to Schneider et al.

    Kobayashi J, Murase Y, Kawashiri MA, Nohara A, Inazu A, Mabuchi H.

    Diabetes Care. 2006 Jan;29(1):181; author reply 181-2. No abstract available. PMID: 16419358 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children.

    Cambuli VM, Musiu MC, Incani M, Paderi M, Serpe R, Marras V, Cossu E, Cavallo MG, Mariotti S, Loche S, Baroni MG.

    J Clin Endocrinol Metab. 2008 Aug;93(8):3051-7. Epub 2008 May 20.PMID: 18492759 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The clinical utility of leptin therapy in metabolic dysfunction.

    Park JY, Gavrilova O, Gorden P.

    Minerva Endocrinol. 2006 Jun;31(2):125-31. Review.PMID: 16682936 [PubMed - indexed for MEDLINE]Related articles

    19.

    A nonsense mutation in the Arg345 of the insulin receptor gene in a Japanese type A insulin-resistant patient.

    Hashiramoto M, Osawa H, Ando M, Murakami A, Nishimiya T, Nakano M, Nishida W, Onuma H, Makino H.

    Endocr J. 2005 Aug;52(4):499-504.PMID: 16127220 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Adiponectin--insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension.

    Papadopoulos DP, Makris TK, Perrea D, Papazachou O, Daskalaki M, Sanidas E, Votteas V.

    Blood Press. 2008;17(1):50-4.PMID: 18568692 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity